Cargando…
Case report: Identification of acute promyelocytic leukemia during osimertinib resistance followed by granulocyte colony-stimulating factor and pembrolizumab
BACKGROUND: The occurrence of acute promyelocytic leukemia (APL) during the management of lung cancer is rare and life-threatening. It was mainly reported to be secondary to chemoradiotherapy. A few studies reported an increased incidence of therapy-related acute promyelocytic leukemia (t-APL) after...
Autores principales: | Tian, Huohuan, Yang, Linhui, Hou, Wang, Wu, Yu, Dai, Yang, Yu, Jiang, Liu, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880289/ https://www.ncbi.nlm.nih.gov/pubmed/36713543 http://dx.doi.org/10.3389/fonc.2022.1032225 |
Ejemplares similares
-
Granulocyte‐colony Stimulating Factor and Retinoic Acid Cooperatively Induce Granulocytic Differentiation of Acute Promyelocytic Leukemia Cells in vitro
por: Nakamaki, Tsuyoshi, et al.
Publicado: (1989) -
Proliferative Effect of Human Granulocyte Colony‐stimulating Factor on Blast Cells of Acute Promyelocytic Leukemia
por: Kitano, Kiyoshi, et al.
Publicado: (1988) -
Granulocyte Colony-Stimulating Factor Receptor Mutations in Myeloid Malignancy
por: Liongue, Clifford, et al.
Publicado: (2014) -
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide
por: Bota, Daniela A., et al.
Publicado: (2022) -
Granulocyte colony-stimulating factor potentiates all-trans retinoic acid-induced granulocytic differentiation in acute promyelocytic leukemia cell line HT93A
por: Uchino, Yoshihito, et al.
Publicado: (2015)